ARTICLE | Clinical News
Horizant gabapentin enacarbil update
October 14, 2013 7:00 AM UTC
XenoPort and the Willis-Ekbom Disease (WED) Foundation began the Patient Odyssey survey in patients with RLS to evaluate challenges of long-term disease management, quality of life, emotional burden a...